Publication | Closed Access
Effects of <scp><i>CYP2C19</i></scp> genetic polymorphisms on the pharmacokinetics of lacosamide in Korean patients with epilepsy
20
Citations
20
References
2022
Year
Genetic polymorphisms of the CYP2C19 gene affect the serum LCM concentration. Because efficacy and toxicity are apparently related to serum LCM levels, the genetic phenotype of CYP2C19 should be considered when prescribing LCM for patients with epilepsy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1